HCA Healthcare (HCA) – Investment Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for HCA Healthcare (NYSE: HCA):

• 11/8/2024 – HCA Healthcare had its price target lowered by analysts at Barclays PLC from $396.00 to $392.00. They now have an “overweight” rating on the stock.
• 11/6/2024 – HCA Healthcare had its price target raised by analysts at Wells Fargo & Company from $395.00 to $400.00. They now have an “equal weight” rating on the stock.
• 11/4/2024 – HCA Healthcare was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating.
• 10/28/2024 – HCA Healthcare had its price target lowered by analysts at KeyCorp from $475.00 to $420.00. They now have an “overweight” rating on the stock.
• 10/28/2024 – HCA Healthcare had its price target raised by analysts at Oppenheimer Holdings Inc. from $390.00 to $400.00. They now have an “outperform” rating on the stock.
• 10/28/2024 – HCA Healthcare had its price target lowered by analysts at TD Cowen from $450.00 to $440.00. They now have a “buy” rating on the stock.
• 10/22/2024 – HCA Healthcare had its price target raised by analysts at Wells Fargo & Company from $365.00 to $395.00. They now have an “equal weight” rating on the stock.
• 10/11/2024 – HCA Healthcare is now covered by analysts at KeyCorp. They set an “overweight” rating and a $475.00 price target on the stock.
• 10/10/2024 – HCA Healthcare was upgraded by analysts at KeyCorp to a “strong-buy” rating.
• 10/1/2024 – HCA Healthcare had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $392.00 price target on the stock.

HCA Healthcare Trading Down 2.1 %

Shares of HCA stock opened at $350.35 on Wednesday. The firm has a market capitalization of $88.74 billion, a P/E ratio of 15.73, a price-to-earnings-growth ratio of 1.36 and a beta of 1.68. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The firm’s fifty day simple moving average is $388.86 and its 200 day simple moving average is $356.86. HCA Healthcare, Inc. has a 1 year low of $229.28 and a 1 year high of $417.14.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.75%. HCA Healthcare’s payout ratio is presently 11.85%.

Insider Activity

In related news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On HCA Healthcare

Several hedge funds have recently added to or reduced their stakes in HCA. Vanguard Group Inc. increased its position in shares of HCA Healthcare by 0.4% in the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock worth $5,666,569,000 after purchasing an additional 60,304 shares during the period. Capital World Investors grew its position in HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after acquiring an additional 1,019,750 shares during the last quarter. Darsana Capital Partners LP grew its position in HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after acquiring an additional 400,000 shares during the last quarter. TD Asset Management Inc boosted its stake in shares of HCA Healthcare by 2.7% during the second quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock valued at $238,110,000 after purchasing an additional 19,812 shares in the last quarter. Finally, Epoch Investment Partners Inc. boosted its stake in shares of HCA Healthcare by 16.4% during the second quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock valued at $203,002,000 after purchasing an additional 88,948 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.